Regulating Nanomedicine – Can the FDA handle it, Medicine, Page 18
| ||||||
| ||||||
| Note : Best viewed in FF3 or above, IE7 or above | ||||||
| Page(s): 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 | ||||||
Other similar topics highly read Comparative Studies on Antioxidant and Free Radical Scavenging Activities of Moringa Oleifera (Lam.) Author: Khushbu Goel (Fellow) Reads: 687 | ||||||
| Page content: 29. Reed, S.D., Reed, Anstrom, K.J., Seils, D.M., Califf, R.M., Schulman, K.A. (2008). Use of Larger Versus Smaller DrugSafety Databases Before Regulatory Approval: The TradeOffs. Health Affairs 27(5):360370. 30. Fender, J. (2008). The FDA and Nano: Big Problems with Tiny Technology. ChicagoKent Law Review 83:1063. 31. Ludlow, K. Bowman D. M., and Kirk, D. D. (2009). Hitting the mark or falling short with nanotechnology regulation? Trends in Biotechnology 27(11):615620. 32. Hoban, T.J. (1995) The construction of food biotechnology as a social issue. In: Eating Agendas: Food and Nutrition as Social Problems (Maurer, D. and Sobal, J., eds), pp. 189212, Aldine de Gruyter. 18 | ||||||
